Get notified when NEOG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRemoved Risk Disclosures
- Material Weakness In Internal Control Over Financial Reporting (removed) — The prior material weakness in internal control over financial reporting has been remediated, as the current filing states that disclosure controls and procedures are effective.
- Material Weakness (removed) — The material weakness disclosed in the prior year is no longer present in the current filing, indicating remediation.
Neogen's first-quarter revenue rose 6.5% to $222.8M, but the company swung to a net loss of $11.9M from a year-ago profit of $36.3M, which the company attributes to $76.4 million gain recognized on the sale of our Cleaners and Disinfectants business in the prior year.
Filed October 7, 2026 · Period ending August 31, 2026 · Compared to 10-Q Oct 9, 2025 · ~2 min read
Key Changes
-
high
Revenue increased 6.5% to $222.8M, driven by $16.9 million growth in business, reflecting continued strength in our indicators and pathogens product line, as well as the current year benefit of distributor inventory adjustments in the prior year and timing of customer orders in the current quarter, and a favorable foreign exchange rate impact of $1.6 million.
-
medium
Gross margin expanded to 47.4% from 45.4%.
-
medium
Operating loss narrowed to $1.8M from $16.1M.
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade NEOG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 7, 2026 · How we verify